Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026)

Viemed Healthcare (VMD) posted Cash from Investing Activities of -$5.5 million for Q1 2026, up 27.94% on a QoQ basis from -$7.6 million in Q4 2025, and up 35.7% year-over-year from -$4.0 million in Q1 2025.

Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Viemed Healthcare's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$5.5 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 35.7% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.1 million (down 39.15% YoY) and the FY2025 annual result came in at -$50.2 million, down 63.41% from the prior year.
  • Cash from Investing Activities was -$5.5 million for Q1 2026 at Viemed Healthcare, up from -$7.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.7 million in Q2 2025 and bottomed at -$32.3 million in Q3 2025.
  • A 5-year average of -$9.6 million and a median of -$7.4 million in 2022 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 84.53% in 2025, while the deepest fall reached 549.97% in 2025.
  • Viemed Healthcare's Cash from Investing Activities stood at -$7.4 million in 2022, then decreased by 1.56% to -$7.5 million in 2023, then dropped by 22.75% to -$9.2 million in 2024, then grew by 17.24% to -$7.6 million in 2025, then increased by 27.94% to -$5.5 million in 2026.
  • Business Quant data shows VMD's Cash from Investing Activities at -$5.5 million in Q1 2026, -$7.6 million in Q4 2025, and -$32.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.73 Bn 176.43 Bn 6.27 Bn -20.32 Bn
2 Stryker 129.05 Bn 126.17 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.63 Bn 67.18 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.43 Bn 44.76 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.14 Bn 25.85 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.89 Bn 26.32 Bn - -
9 Koninklijke Philips 24.25 Bn 21.12 Bn 2.07 Bn -475.32 Mn
10 Viemed Healthcare 464.60 Mn 454.84 Mn 42.83 Mn -5.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.49 Mn
Mar 31, 2026 -5.49 Mn
Dec 31, 2025 -7.61 Mn
Dec 31, 2025 -7.61 Mn
Sep 30, 2025 -32.30 Mn
Sep 30, 2025 -32.30 Mn
Jun 30, 2025 -1.73 Mn
Jun 30, 2025 -1.73 Mn
Mar 31, 2025 -8.53 Mn
Mar 31, 2025 -8.53 Mn
Dec 31, 2024 -9.20 Mn
Dec 31, 2024 -9.20 Mn
Sep 30, 2024 -4.97 Mn
Sep 30, 2024 -4.97 Mn
Jun 30, 2024 -11.17 Mn
Jun 30, 2024 -11.17 Mn
Mar 31, 2024 -5.37 Mn
Mar 31, 2024 -5.37 Mn
Dec 31, 2023 -7.49 Mn
Dec 31, 2023 -7.49 Mn